Company / EPS (Basic)
Mirum Pharmaceuticals, Inc. EPS (Basic) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$4.00
FY2025
5-year range
-$4.01 / -$2.77
FY2022-FY2025
Trend
+0.2%
vs FY2024
Sector context
#168 of 208
Health Care
What the data says
Mirum Pharmaceuticals, Inc.'s eps (basic) of $-4.00 is lower than 81% of companies in the Health Care sector (FY2025). Declined from $-2.77 to $-4.00 over the past 2 years.
Based on SEC 10-K filings.
-4.00 in FY2025.
Declined from $-2.77 to $-4.00 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 208This company -$4.00 Sector average -$0.96
▼
-315.3% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 0.2% year-over-year.
- Ranks #168 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.00 | +0.2% |
| FY2024 | -$4.01 | -44.8% |
| FY2023 | -$2.77 | +0.0% |
| FY2022 | -$2.77 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026